Pharm- Lung disease Flashcards
Short acting beta agonist- Indications
- Asthma: Immediate relief of symptoms- most effective med for acute bronchospasm
- Intermediate duration- 3-6 hrs
- Only for use <2x/ week
COPD: Long term use for bronchodilation
Short acting beta agonist- MOA
Relaxes bronchial smooth muscle- beta 2 agonist
Short acting beta agonist- AE
- Nervousness, tremor, HA, palpitations
Short acting beta agonist- Names
Albuterol, levalbuterol, metaproternol
Long acting beta agonist- Names
salmeterol, formoterol
Long acting beta agonist- Indications
- Long acting relief of symptoms- not control
Long acting beta agonist- MOA
- Long acting beta agonist- relaxes bronchial smooth muscle
Long acting beta agonist- AE
- Black box: Increased risk of death if used as long term controller
Mast cell stabilizers- Names
Cromolyn
Leukotriene modifiers- Names
montelukast, zafirlukast, zileuton
Leukotriene modifiers- Indications
Alternative controller for concern about steroids in children
Mast cell stabilizers- MOA
Inhibit inflammatory response of mast cells in lungs
Inhaled corticosteroids- Names
beclomethasone, fluticasone, triamcinolone
Inhaled corticosteroids- AE
- Low side effect profile
- HPA axis may be suppressed in children, reducing growth
Anticholinergics- MOA
Block Ach to allow relaxation of bronchial smooth muscle
Anticholinergics- Names
ipatropium, tiotropium
Anticholinergics- Indications
COPD- allows chronic bronchodilation
Anticholinergics- AE
- Dry mouth and oropharynx
- No systemic anticholinergic side effects
Inhaled corticosteroids- Indications
Low dose- beginning at Asthma step 2
Inhaled corticosteroids- MOA
Decrease underlying airway inflammation- eosinophils, marcophages, T- lymphocytes
Mast cell stabilizers- AE
Irritation, dry throat, bitter taste
Phosphodiesterase inhibitor- Theophylline- Indications
Alternative treatment in asthma/ COPD
Phosphodiesterase inhibitor- Theophylline- MOA
Antagonizes adenosine receptors- increases cAMP
Phosphodiesterase inhibitor- Theophylline- AE
N/V/HA insomnia